MAX relief junior
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2025-12-10
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 01:22:27
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient (in each 5 mL)
Acetaminophen 160 mg
OTC - PURPOSE SECTION
Purpose
Pain Reliever/Fever Reducer
INDICATIONS & USAGE SECTION
Uses
- temporarily
- reduces fever
- relieves minor aches and pains due to:
- the common cold
- flu
- headache
- sore throat
- toothache
WARNINGS SECTION
Warnings
Liver Warning: This product contains acetaminophen. Severe liver damage may occur if your child takes:
- more than 5 doses in 24 hours, which is the maximum daily amount
- with other drugs containing acetaminophen
Allergy alert: Acetaminophen may cause severe skin reactions.
Soar throat warning:if sore throat is severe, persists or more than 2 days, isaccompanied or followed by fever headache, rash, nausea, or vomiting, consult a doctor promptly.
Do not use
- with any other drug containing acetaminophen (prescription or nonprescription).
- If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
Ask a doctor before use if your child has liver disease.
Ask a doctor or pharmacist before use if your child is taking the blood thinning drug warfarin.
When using this product: Do not exceed recommended dose (see overdose warning)
Stop use and ask a doctor if
- pain gets worse or lasts more than 5 days
- fever gets worse or lasts more than 3 days
- new symptoms occur
- redness or swelling is present. These could be signs of a serious condition.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
If pregnant or breast-feeding, ask a health professional before use
SPL UNCLASSIFIED SECTION
Overdose warning. In case of overdose, get medical help or contact a Paoison Control Center (1-800-222-1222) right away. Quick medical attention is critical even if you do not notice any signs or symptoms.
DOSAGE & ADMINISTRATION SECTION
Directions
- this product does not contain direction or complete warnings for adult use
- Shake well before using
- ml = milliliter
- find right dose on chart below
- if possible, use weight to dose; otherwise use age
- use only the enclosed dosing cup designed for use with this product. Do not use any other dosing device.
- if needed, repeat dose every 4 hourswhile symptoms last
- do not give more than 5 times in 24 hours
- do not give more than 5 days unless directed by doctor.
| Weight (lbs.) | Age (yrs.) | Dose (tsp or mL) |
| under 24 | under 2 | ask a doctor |
| 24 to 35 | 2 to 3 | 1 tsp or 5 mL |
| 36 to 47 | 4 to 5 | 1 1/2 tsp or 7.5 mL |
| 48 to 59 | 6 to 8 | 2 tsp or 10 mL |
| 60 to 71 | 9 to 10 | 2 1/2 tsp or 12.5 mL |
| 72 to 95 | 11 | 3 tsp or 15 mL |
Other Information store at room temperature 15 o-30 oC (59 o-86 oF). Protect from Freezing. Protect from light.
INACTIVE INGREDIENT SECTION
Inactive ingredients: amydrous citric acid, bubble gum flavor, glycerin, polyethylene glycol400, punfied water, saccharin sodium, sodium benzoate, sodium citrate, sorbttol solution, sucralose.
OTC - QUESTIONS SECTION
DISTRIBUTED BY:
ATLANTIC BIOLOGICALS CORP.
MIAMI, FL 33179
This product is not manufactured by or distributed by McNeil Consumer Healthcare, owner of the registered trademark Tylenol Eixir.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 307675 | acetaminophen 160 MG in 5 mL Oral Solution | PSN | 2 |
| 307675 | acetaminophen 32 MG/ML Oral Solution | SCD | 2 |
| 307675 | acetaminophen 160 MG per 5 ML Oral Solution | SY | 2 |
| 307675 | acetaminophen 325 MG per 10.15 ML Oral Solution | SY | 2 |
| 307675 | acetaminophen 650 MG per 20.3 ML Oral Solution | SY | 2 |
| 307675 | acetaminophen 80 MG per 2.5 ML Oral Solution | SY | 2 |
| 307675 | APAP 32 MG/ML Oral Solution | SY | 2 |
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | Data Matrix | (01)00317856004510(21)XXXXXXXXXXX(10)XXXXXXXXXX(17)010101 | GTIN-14: 00317856004510 GTIN-12: 317856004510 UPC-A: 317856004510 EAN-13: 0317856004510 GTIN storage (14 digits): 00317856004510 | 17856-0045-01 Rev. 2 Label.jpg |
| Barcode | Data Matrix | (01)00317856004527(21)XXXXXXXXXXX(10)XXXXXXXXXX(17)010101 | GTIN-14: 00317856004527 GTIN-12: 317856004527 UPC-A: 317856004527 EAN-13: 0317856004527 GTIN storage (14 digits): 00317856004527 | 17856-0045-02 Rev. 2 Label.jpg |
| Barcode | Data Matrix | (01)00317856004534(21)XXXXXXXXXXX(10)XXXXXXXXXX(17)010101 | GTIN-14: 00317856004534 GTIN-12: 317856004534 UPC-A: 317856004534 EAN-13: 0317856004534 GTIN storage (14 digits): 00317856004534 | 17856-0045-03 Rev. 2 Label.jpg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0045-1 | MAX relief junior | 48 in 1 BOX, UNIT-DOSE | LIQUID | 48 | 2 | |
| 17856-0045-2 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-3 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-4 | MAX relief junior | 120 in 1 BOX, UNIT-DOSE | LIQUID | 120 | 2 | |
| 17856-0045-5 | MAX relief junior | 7.5 mL in 1 SYRINGE | LIQUID | 7.5 | 2 | |
| 17856-0045-6 | MAX relief junior | 1.25 mL in 1 SYRINGE | LIQUID | 1.25 | 2 | |
| 17856-0045-7 | MAX relief junior | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 2 | |
| 17856-0045-8 | MAX relief junior | 2.5 mL in 1 SYRINGE | LIQUID | 2.5 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71399-0021-4 | ML - Milliliter | 71399-0021 | 8278cfd9-c177-40ff-8f8d-24c0f1587272 | 1 | 2023-06-06 |
| 71399-0021-6 | ML - Milliliter | 71399-0021 | 819361d4-8afa-4310-aee7-01ecd32432c7 | 1 | 2023-06-06 |
| 71399-0021-8 | ML - Milliliter | 71399-0021 | 54fc8375-8629-49ea-bd26-ac44e68c341b | 1 | 2023-06-06 |
Products#
Every source-derived product name is available through these pages.
- MAX relief junior
- Acetaminophen
- ANHYDROUS CITRIC ACID
- GLYCERIN
- POLYETHYLENE GLYCOL 400
- PROPYLENE GLYCOL
- WATER
- SACCHARIN SODIUM
- SODIUM BENZOATE
- SODIUM CITRATE
- SORBITOL
- SUCRALOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17856-0045 | 17856-0045-5, 17856-0045-1, 17856-0045-6, 17856-0045-2, 17856-0045-7, 17856-0045-3, 17856-0045-8, 17856-0045-4 |
| 71399-0021 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ANHYDROUS CITRIC ACID | XF417D3PSL | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| PROPYLENE GLYCOL | 6DC9Q167V3 | IACT |
| WATER | 059QF0KO0R | IACT |
| SACCHARIN SODIUM | SB8ZUX40TY | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| SODIUM CITRATE | 1Q73Q2JULR | IACT |
| SORBITOL | 506T60A25R | IACT |
| SUCRALOSE | 96K6UQ3ZD4 | IACT |
| ACETAMINOPHEN | 362O9ITL9D | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| MAX relief junior | ACETAMINOPHEN | Akron Pharma Inc. | 0e43b885-3843-4f11-9a53-02a38c228313 | 2026-08-31 | Warnings | 71399-0021 |
| MAX relief junior | ACETAMINOPHEN | ATLANTIC BIOLOGICALS CORP. | ff1f6f82-0c7c-4e3f-a2bd-3185e16fa770 | 2025-12-10 | Warnings | 17856-0045-2 17856-0045-8 17856-0045-7 17856-0045-3 17856-0045-1 17856-0045-5 17856-0045-6 17856-0045-4 17856-0045 17856004502 17856004506 17856004503 17856004508 17856004505 17856004501 17856004507 17856004504 459c7291-7d06-5c29-e063-6394a90a8742 ff1f6f82-0c7c-4e3f-a2bd-3185e16fa770 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.


